Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,058,991 papers from all fields of science
Search
Sign In
Create Free Account
tumor protein D52
Known as:
Protein N8
, TPD52
, D52
Expand
Tumor protein D52 (224 aa, ~24 kDa) is encoded by the human TPD52 gene. This protein is involved in morphogenesis.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
5 relations
Genes, Regulator
Morphogenesis
TPD52 gene
TPD52 wt Allele
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Silencing of NAMPT leads to up-regulation of insulin receptor substrate 1 gene expression in U87 glioma cells
D. Tsymbal
,
D. Minchenko
,
O. Y. Luzina
,
O. O. Riabovol
,
S. V. Danilovskyi
,
O. Minchenko
Endocrine Regulations
2020
Corpus ID: 211229701
Abstract Objective. The aim of the present study was to investigate the effect of adipokine NAMPT (nicotinamide…
Expand
2019
2019
MicroRNA-449b-5p suppresses cell proliferation, migration and invasion by targeting TPD52 in nasopharyngeal carcinoma.
W. Yin
,
Lei Shi
,
Yanjiao Mao
Journal of Biochemistry (Tokyo)
2019
Corpus ID: 198933614
Nasopharyngeal carcinoma (NPC) is an important type of head and neck malignant cancer with geographical distribution. MicroRNA…
Expand
2019
2019
miR-107 Enhances the Sensitivity of Breast Cancer Cells to Paclitaxel
Changpo Ma
,
Xuejun Shi
,
Wenchao Guo
,
Jianxin Niu
,
Guangshun Wang
Open Medicine
2019
Corpus ID: 189818932
Abstract Breast cancer remains the most commonly diagnosed cancer in Chinese women. Paclitaxel (PTX) is a chemotherapy medication…
Expand
2017
2017
Expression of tumor growth related genes in IRE1 knockdown U87 glioma cells: effect of hypoxia
O. Minchenko
,
O. Y. Luzina
,
O. Hnatiuk
,
D. Minchenko
,
I. A. Garmash
,
O. Ratushna
2017
Corpus ID: 43927853
We have studied the effect of IRE1 signaling enzyme knockdown as well as hypoxia on the expression of genes encoding the…
Expand
2017
2017
All-trans-retinoic acid stimulates overexpression of Tumor protein D 52 ( TPD 52 , isoform 3 ) and neuronal differentiation of IMR-32 cells † Running title : TPD 52 role in RA induced differentiation…
S. S. Kotapalli
,
Chandrashekhar Dasari
,
+4 authors
R. Ummanni
2017
Corpus ID: 207866722
2013
2013
Tumor protein D52 represents a negative regulator of ATM protein levels
Yuyan Chen
,
Alvin Kamili
,
Jayne R. Hardy
,
G. Groblewski
,
K. Khanna
,
J. Byrne
Cell Cycle
2013
Corpus ID: 876733
Tumor protein D52 (TPD52) is a coiled-coil motif bearing hydrophilic polypeptide known to be overexpressed in cancers of diverse…
Expand
2011
2011
Clinical Significance of Tumor Protein D52 Immunostaining in a Large Series of Ewing's Sarcoma Family of Tumors
I. Machado
,
J. López-Guerrero
,
+5 authors
A. Llombart-Bosch
Pediatric and Developmental Pathology
2011
Corpus ID: 23241625
To the Editor, Tumor protein D52 (TPD52) has been identified in the chromosome 8q21 amplicon and is involved in cellular…
Expand
2011
2011
30. MAL2 and tumour protein D52 (TPD52) overexpression in ovarian carcinoma, association with histological subtype and clinical outcome
J. Byrne
,
R. Murali
,
+9 authors
P. M. O’Brien
2011
Corpus ID: 76039081
2009
2009
Award Number: W81XWH-08-1-0660 TITLE: TPD52: A Novel Vaccine Target for Prostate Cancer
Laura A. Sullivan
,
J. Byrne
2009
Corpus ID: 53318895
Expression studies have consistently identified tumor protein D52 (TPD52) overexpression in tumor cells. Murine TPD52 (mD52…
Expand
2004
2004
Secretagogue-induced translocation of CRHSP-28 within an early apical endosomal compartment in acinar cells.
Diana D. H. Thomas
,
Ning Weng
,
G. Groblewski
American Journal of Physiology - Gastrointestinal…
2004
Corpus ID: 15431516
Ca(2+)-regulated heat-stable protein (CRHSP-28) is a member of the TPD52 protein family that has been shown to regulate Ca(2…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE